Tafamidis Meglumine

A soft gelatin capsule formulation containing the meglumine salt form of tafamidis, a small molecule and pharmacological chaperone with potential disease-modifying activity. Tafamidis binds to and stabilizes wild-type and variant (V122I) transthyretin (TTR), thereby preventing tetramer dissociation into monomers; this prevents misfolding of the TTR protein and inhibits the formation of TTR amyloid fibrils and the subsequent deposition of these insoluble protein clusters in peripheral nerve tissues and organs. TTR is a 127 amino acid transport protein for thyroxine and retinol and is secreted by the liver. (NCI Thesaurus)

YOU MAY ALSO LIKE

TAF9 wt Allele

Human TAF9 wild-type allele is located within 5q11.2-q13.1 and is approximately 19 kb in length. This allele, which encodes transcription initiation factor…

TAF9 Gene

This gene is involved in transcriptional initiation and signal transduction.

TAF8 wt Allele

Human TAF8 wild-type allele is located in the vicinity of 6p21.1 and is approximately 37 kb in length. This allele, which encodes…

TAF8 Gene

This gene plays a role in transcriptional initiation and is required for basal and activator-dependent transcription.

TAF7L wt Allele

Human TAF7L wild-type allele is located in the vicinity of Xq22.1 and is approximately 25 kb in length. This allele, which encodes…

TAF7L Gene

This gene plays a role in transcriptional initiation and has testis-specific expression.